|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 3.580 USD | +4.07% |
|
+9.48% | -25.88% |
| 09-21 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to S&P Global BMI Index | CI |
| 09-11 | Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each | MT |
Stock exchange
Quotes 5-day view: Relmada Therapeutics, Inc.
Delayed Quote Nasdaq
| 26/10/2026 | 27/10/2026 | 28/10/2026 | 29/10/2026 | 30/10/2026 | |
|---|---|---|---|---|---|
| Last | $3.230 | $3.210 | $3.350 | $3.440 | $3.580 |
| Volume | 775,832 | 1,673,658 | 1,614,702 | 1,610,447 | 1,413,755 |
| Change | -1.22% | -0.62% | +4.36% | +2.69% | +4.07% |
| Opening | $3.300 | $3.220 | $3.210 | $3.380 | $3.420 |
| High | $3.305 | $3.330 | $3.360 | $3.485 | $3.655 |
| Low | $3.215 | $3.175 | $3.180 | $3.290 | $3.300 |
Performance
| 1 day | +4.07% | ||
| 1 week | +9.48% | ||
| 1 month | -5.04% | ||
| 3 months | -32.58% | ||
| 6 months | -52.39% | ||
| Current year | -25.88% | ||
| 1 year | +58.41% | ||
| 3 years | +19.73% | ||
| 5 years | -84.75% | ||
| 10 years | -22.17% |
Volumes
marketsDaily volume
1,413,755
Estimated daily volume
1,413,755
Avg. Volume 20 sessions
1,625,675
Daily volume ratio
0.87
Avg. Volume 20 sessions USD
5,819,916.5
Record volume 1
43,005,379
Record volume 2
33,760,571
Record volume 3
26,026,024
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
381,878,048
Net sales (USD)
0
Number of employees
17
Sales / Employee (USD)
0
Free-Float
96.77%
Free-Float capitalization (USD)
369,544,246
Average Daily Capital Traded
1.52%
Indicators
Moving average 5 days
3.362
Moving average 20 days
3.305
Moving average 50 days
3.864
Moving average 100 days
4.803
Price spread / (MMA5)
-6.09%
Price spread / (MMA20)
-7.68%
Price spread / (MMA50)
+7.94%
Price spread / (MMA100)
+34.16%
RSI 9 days
55.26
RSI 14 days
47.7
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.07% | +9.48% | +58.41% | +19.73% | 382M | |
| -0.62% | -1.87% | +42.87% | +64.15% | 63.77B | |
| +0.35% | +3.20% | +14.40% | +81.76% | 56.37B | |
| +0.53% | +1.96% | +16.24% | +103.35% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +47.83% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +98.80% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +866.21% | 41B | |
| +3.27% | +47.96% | +112.84% | +96.58% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +46.95% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +349.24% | 24.7B | |
| Average | +0.71% | +7.73% | +48.66% | +177.46% | 39.47B | |
| Weighted average by Cap. | +0.18% | +5.45% | +48.00% | +176.52% |
Historical Quotes: Relmada Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
a3.oY1CljwXMuC79jcvxWh4lV4ItFFTGNC2imjTFOJbYak.9tR1wg9dWZrVj1N2kxIv4QswxmA0UeGC-xGrUK83K8_D3wf4VmVeitKhUA
| Date | Price | Volume | Total |
|---|---|---|---|
| 00:00:00 | 3.580 | 139,805 | 1,265,248 |
| 23:59:59 | 3.595 | 258 | 1,125,443 |
| 23:59:59 | 3.590 | 708 | 1,125,185 |
| 23:59:59 | 3.590 | 200 | 1,124,477 |
| 23:59:59 | 3.595 | 400 | 1,124,277 |
| 23:59:58 | 3.595 | 100 | 1,123,877 |
| 23:59:58 | 3.595 | 800 | 1,123,777 |
| 23:59:58 | 3.595 | 390 | 1,122,977 |
| 23:59:57 | 3.600 | 100 | 1,122,587 |
Price Extremes
| 1 week | 3.18 |  | 3.66 |
| 1 month | 3.07 | | 3.73 |
| Current year | 3.07 | | 8 |
| 1 year | 2.15 | | 8 |
| 3 years | 0.24 | | 8 |
| 5 years | 0.24 | | 38.68 |
| 10 years | 0.24 | | 54 |
Monthly variations
Annual variations
| 2026 | -25.88% | ||
| 2025 | +828.85% | ||
| 2024 | -87.44% | ||
| 2023 | +18.62% | ||
| 2022 | -84.51% | ||
| 2021 | -29.75% | ||
| 2020 | -17.77% | ||
| 2019 | +747.83% | ||
| 2018 | +53.33% | ||
| 2017 | -31.19% | ||
| 2016 | -56.40% | ||
| 2015 | -83.87% | ||
| 2014 | +3.33% |
- Stock Market
- Stocks
- RLMD Stock
- Quotes Relmada Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
